BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17654024)

  • 1. Preparation, characterization, and scale-up of ketoconazole with enhanced dissolution and bioavailability.
    Elder EJ; Evans JC; Scherzer BD; Hitt JE; Kupperblatt GB; Saghir SA; Markham DA
    Drug Dev Ind Pharm; 2007 Jul; 33(7):755-65. PubMed ID: 17654024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S
    J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs.
    Rogers TL; Gillespie IB; Hitt JE; Fransen KL; Crowl CA; Tucker CJ; Kupperblatt GB; Becker JN; Wilson DL; Todd C; Broomall CF; Evans JC; Elder EJ
    Pharm Res; 2004 Nov; 21(11):2048-57. PubMed ID: 15587927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F; Ozcan I; Guneri T
    Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of phospholipids in combination with hydrophilic carriers for enhancement of the dissolution and oral bioavailability of imidazole antifungal Class II drugs.
    Abu Hashim II; Ghazy NF; El-Shabouri MH
    Pharmazie; 2015 Nov; 70(11):706-15. PubMed ID: 26790186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole-
    Martin F; Pop M; Kacso I; Grosu IG; Miclăuş M; Vodnar D; Lung I; Filip GA; Olteanu ED; Moldovan R; Nagy A; Filip X; Bâldea I
    Mol Pharm; 2020 Mar; 17(3):919-932. PubMed ID: 31986050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.
    Rogers TL; Nelsen AC; Sarkari M; Young TJ; Johnston KP; Williams RO
    Pharm Res; 2003 Mar; 20(3):485-93. PubMed ID: 12669973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole.
    Heo MY; Piao ZZ; Kim TW; Cao QR; Kim A; Lee BJ
    Arch Pharm Res; 2005 May; 28(5):604-11. PubMed ID: 15974450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-milling of telmisartan with poly(vinyl alcohol)--An alkalinizer free green approach to ensure its bioavailability.
    Isaac J; Ganguly S; Ghosh A
    Eur J Pharm Biopharm; 2016 Apr; 101():43-52. PubMed ID: 26829378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Manufacturing Methods on Dissolution and Absorption of Ketoconazole in the Presence of Organic Acid as a pH Modifier.
    Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
    AAPS PharmSciTech; 2017 May; 18(4):1203-1212. PubMed ID: 27431914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
    Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
    AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Assessment of Supersaturation/Precipitation and Biological Membrane Permeation of Poorly Water-Soluble Drugs: A Case Study With Albendazole and Ketoconazole.
    Kataoka M; Takeyama S; Minami K; Higashino H; Kakimi K; Fujii Y; Takahashi M; Yamashita S
    J Pharm Sci; 2019 Aug; 108(8):2580-2587. PubMed ID: 30885658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle formation and growth during in vitro dissolution of ketoconazole solid dispersion.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Hanefeld A; Fischbach M; Maio M; Tan RB
    J Pharm Sci; 2011 Jul; 100(7):2876-85. PubMed ID: 21290385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs.
    Rasenack N; Müller BW
    Pharm Res; 2002 Dec; 19(12):1894-900. PubMed ID: 12523671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.